Member Info for MadChatter

Boom

Here we go!!

The rns this had the other day was rediculously good. When funding rns hits this will easily hit at least 7p imo.

Speaking to someone yesterday who works for a business in China (not sure which city). He said most businesses (in that city) on complete shutdown. Dont know how much longer that can last.

The only known facts about this product so far is we've had interest from 10 countries and we've sold £49k.

Logic tells me i really should wait to see orders in £££ before buying.

But I'll keep a very close eye on this today

If the gov/ NHS bought enough tests for 1m people that would be say £5m revenue. Impressive for company mcap beliw £30m. Not so impressive if the mcap is £250m (£5 per share).

Not to mention the 1m could take them 6 months to make for all we know.

I probably will buy in again monday morning, but imo this is only fairly priced on current information up to say 50p. Thats including nhs deal.

Just researching more into this. In their admission document i see they had 3 production sites, around 120 staff.

They've sold off 2, and by end of march will have relocated entirely (afaik) to just camberley. Which has been fitted with decent R&D.

Their last sales update suggested because of lack of funding late last year they wont return to "normal" production until late H1.

What normal means i cannot find anywhere.

By the sounds of things they need to license asap.

Imo shareholders need a technical call arranged.

To address the clinical definition of research only tests (which my understanding is not for home use), to ascertain production capability.

They need deals here of at the very least £250k per deal. And over £1m of deals very soon (within next 2 weeks imo) for the mcap to be sustainable at even todays value.

@achilles
No. The did not sell 10,000 kits. They sold 10,000 tests.

Huge difference in revenues.

I'm going to try and look into tjrir productivity capacity, but they only have a very short window of time for major deals imo before someone like Roche controls it.

I'd like to see confirmed orders with it explicitly clear the monetary value of orders. They have to be huge as well, to support a company this mcap already.

Roche already are working on this, and they are worth billions

https://www.google.co.uk/amp/s/www.bloomberg.com/amp/news/articles/2020-01-30/roche-s-new-virus-test-could-speed-up-screening-of-patients

@LB
I think the genetic profile was shared by China on 11th

I'm out for now, until I see more substantial orders confirmed. But 16p to 41 not bad for a days work.

Fair play degsy, if you can actually buy in bulk and export to China make a fair bit of money.

I am hearing from a few people the £46k on day 1 is correct. But still, very early days here.

Do people honestly think this would be clapping themselves on the back about only £46k sales?! The costs alone would be higher than revenue if they produced tests one at a time.

1.8m euro cash held as at end of Dec 2019. No doubt these big sales are cash mostly up front as well.

They don't need funding. They cancelled £3m of loan notes late last year.

This is not the only company in the world selling quick coronavirus testing kits. There are 2 companies in China as well.

However this is the only company on UK or US markets AFAIK that you can trade in with tests this quick.

Expecting some huge deals to come out of this weekend middle East conference.

My view on moral question is that the more tests kits there are out there in the world right now the better. God willing 90% of them can be thrown in the bin as not needed!

@skier. I believe that's the clinical difference between products sold for home use, and ones used in a lab. This is definitely not for home use.